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The CNS is supported and defended by two different macro-
phagepopulations:CNS-residentmicrogliaandCNS-inﬁltrating
macrophages (reviewed in Carson et al. 2007). In histological
sections, these two cell types cannot be reliably distinguished
from one another because CNS-resident microglia express most
(if not all) common macrophage markers. In addition, both cell
types can acquire either stellate or amoeboid morphologies
depending on the CNS micro-environment. Despite this high
degree of similarity, a large number of functional studies using
ﬂow cytometry and irradiation bone marrow chimeric mouse
methodologies have convincingly demonstrated that these
cells are functionally distinct (Hickey and Kimura 1988;
Sedgwick et al. 1991; Vallieres and Sawchenko 2003; Byram
et al. 2004; and reviewed in Ransohoff 2007).
Most tissue macrophages are relatively short-lived and are
continually being replenished from bone marrow-derived
cells (reviewed in Carson et al. 2006a,b and Ransohoff
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Abstract
Two different macrophage populations contribute to CNS
neuroinﬂammation: CNS-resident microglia and CNS-inﬁltrat-
ing peripheral macrophages. Markers distinguishing these two
populations in tissue sections have not been identiﬁed.
Therefore, we compared gene expression between LPS
(lipopolysaccharide)/interferon (IFN)c-treated microglia from
neonatal mixed glial cultures and similarly treated peritoneal
macrophages. Fifteen molecules were identiﬁed by quantative
PCR (qPCR) as being enriched from 2-fold to 250-fold in
cultured neonatal microglia when compared with peritoneal
macrophages. Only three of these molecules (C1qA, Trem2,
and CXCL14) were found by qPCR to be also enriched in
adult microglia isolated from LPS/IFNc-injected CNS when
compared with inﬁltrating peripheral macrophages from the
same CNS. The discrepancy between the in vitro and in vivo
qPCR data sets was primarily because of induced expression
of the ‘microglial’ molecules (such as the tolerance associated
transcript, Tmem176b) in CNS-inﬁltrating macrophages. Bio-
informatic analysis of the 19000 mRNAs detected by TOGA
gene proﬁling conﬁrmed that LPS/IFNc-activated microglia
isolated from adult CNS displayed greater similarity in total
gene expression to CNS-inﬁltrating macrophages than to
microglia isolated from unmanipulated healthy adult CNS.
In situ hybridization analysis revealed that nearly all microglia
expressed high levels of C1qA, while subsets of microglia
expressed Trem2 and CXCL14. Expression of C1qA and
Trem2 was limited to microglia, while large numbers of
GABA+ neurons expressed CXCL14. These data suggest that
(i) CNS-resident microglia are heterogeneous and thus a
universal microglia-speciﬁc marker may not exist; (ii) the CNS
micro-environment plays signiﬁcant roles in determining the
phenotypes of both CNS-resident microglia and CNS-inﬁl-
trating macrophages; (iii) the CNS microenvironment may
contribute to immune privilege by inducing macrophage
expression of anti-inﬂammatory molecules.
Keywords: autoimmunity, Clast 1, Nasu-Hakola, neuro-
degeneration, neuroinﬂammation, Torid.
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reveal that CNS-resident microglia are largely self-renewing
and rarely replenished from the bone marrow. Recent studies
using non-irradiated parabiotic mice have conﬁrmed these
observations (Ajami et al. 2007). Irradiation bone marrow
chimeric mice have also been used to selectively express
major histocompatability complex (MHC) class II in either
the radiation-insensitive (microglia) or radiation-sensitive
compartment (peripheral CNS-inﬁltrating immune cells).
These studies demonstrated that while peripheral immune
cells were highly effective at initiating pro-inﬂammatory
lymphocyte responses, CNS-resident microglia were not
(Hickey and Kimura 1988; Greter et al. 2005). Rather CNS-
resident microglia appeared to play an opposing role either in
limiting pro-inﬂammatory lymphocyte responses or in initi-
ating neuroprotective CD4+ T-cell responses (Byram et al.
2004; Takahasi et al. 2007).
Although CNS-resident microglia cannot be distinguished
histologically from other macrophage populations, they can
be distinguished using ﬂow cytometry. Speciﬁcally, in CNS
cell suspensions, CNS-resident microglia can be distin-
guished from acutely inﬁltrating peripheral macrophages by
their lower levels of CD45 expression. Although the two
levels of CD45 expression do slightly overlap, the bulk of
each population can be reliably distinguished by this method
(Sedgwick et al. 1991; Renno et al. 1995; Carson et al.
1998, 2006a,b; Fig. 1a). The stable differences in CD45
expression levels are also likely to have functional conse-
quences. CD45 (also known as leukocyte common antigen)
is a protein tyrosine phosphatase that has been implicated as
an inhibitory receptor for a CD22; a ligand expressed by both
CNS neurons and B cells (Mott et al. 2004). These data
suggest that CNS neurons should be more effective at
inhibiting inﬁltrating macrophages than CNS-resident
microglia even when both are found in the same inﬂamma-
tory foci! Considered together, these data demonstrate the
continuing need to deﬁne the molecular differences between
CNS-resident microglia and CNS-inﬁltrating macrophages.
Using CD45 expression levels as a cell type speciﬁc maker,
small numbers of microglia and CNS-inﬁltrating macrophag-
es can be isolated from adult rodent CNS by ﬂow cytometric
cell sorting (Sedgwick et al. 1991; Renno et al. 1995; Carson
et al. 1998). However, only a few hundred thousand cells per
brain can be isolated by this method, which is insufﬁcient for
many functional and molecular assays (Carson et al. 1998,
2006a,b). We and others have therefore used primary
microglia from neonatal mixed glial cultures and thioglyco-
late-elicted peritoneal macrophages as models for activated
CNS-resident microglia and CNS-inﬁltrating macrophages,
respectively (Carson et al. 1998, Papenfuss et al. 2007).
Primary cultured microglia from mixed glial cultures have
advantagesoverthecommonmicrogliacelllinesasmodelsfor
microgliainvivo.Primaryculturedmicrogliaarenotoncogene
immortalized and they are differentiated in the presence of
astrocytes and oligodendrocytes. Thioglycolate-elicited peri-
toneal macrophages have advantages over splenic macro-
phages and oncogene-transformed macrophage cell lines in
that they have been recently induced to inﬁltrate the perito-
neum in response to pathogen recognition receptors. Here we
test the predictive nature of these commonly used models to
identify cell-type speciﬁc markers able to distinguish CNS-
resident microglia from CNS-inﬁltrating macrophages.
Materials and methods
Microglia isolation from mixed glial cultures
Mixed glial cultures were prepared as previously described (Carson
et al. 1998, 1999). Brieﬂy, brains from postnatal day 1–3 C57Bl/6J
(a)
(b)
(c)
Fig. 1 Microglia and macrophages isolated from the CNS show similar
patterns of gene expression. (a): CNS-resident microglia (MG-boxed
cells) and acutely inﬁltrating macrophages (MP-boxed cells) can be
isolated from the same LPS/IFNc-injected mouse brain and separated
into two distinct cell populations using ﬂuorescence-activated cell
sorting. Microglia are deﬁned as the Fc receptor positive, CD45lo cells
(left box), and CNS-inﬁltrating macrophages are deﬁned as the Fc
receptor positive, CD45hi cells. (b) qPCR analysis of Tmem176b
expression in microglia isolated from healthy unmanipulated adult CNS
(MG-U), microglia isolated from LPS/IFNc injected mouse CNS (MG-T)
and acutely inﬁltrating macrophages isolated from the same injected
CNS (MP-T). (c) Approximately 19000 different mRNAs were detected
by TOGA gene expression proﬁling of lymphocytes (B cells, CD4+ and
CD8+ T cells) isolated by ﬂow cytometry from lymph nodes of naı ¨ve
adult mice; unactivated CD45lo microglia from unmanipulated healthy
adult mice, activated CD45lo microglia and CD45 high macrophages
isolated by ﬂow cytometry from LPS/IFNc-injected adult murine; and
in vitro unactivated and LPS-activated bone marrow-derived dendritic
cells. Between each of the samples, pair-wise comparisons were made
of the numbers of mRNAs expressed and the relative expression
levels of the approximately total 19000 mRNAs detected by TOGA.
Fromthese comparisons, linear correlationcoefﬁcientswerecalculated
in a pair-wise fashion for each of the samples. The difference index
(numeric values listed at each branch in c) between each sample was
calculated as 1 minus the correlation coefﬁcient.
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dissociated, seeded into T-75 ﬂasks, and maintained in Dulbecco’s
modiﬁed Eagle’s medium, supplemented with 10% fetal bovine
serum and insulin (5 lg/mL). After 3 weeks, mixed glial cultures
were trypsinized and incubated as a single cell suspension in
Dulbecco’s modiﬁed Eagle’s media without phenol red for 30 min at
37 C to allow for the re-expression of trypsinized surface markers.
Microglia were puriﬁed to > 98% by ﬂow cytometry using
phycoerythrin-conjugated antibodies directed against FcR/CD16/
CD32 (Pharmingen, San Diego, CA, USA). Cytoplasmic mRNA
was prepared from isolated cells immediately after isolation as
previously described (Schmid et al. 2002).
Peritoneal macrophage and bone marrow-derived dendritic cell
preparation
Peritoneal macrophages were prepared as previously described
(Carson et al. 1998, 1999). Brieﬂy, 3.0 mL of aged sterile
thioglycolate broth were injected into the peritoneum of C57Bl/
6J mice (Difco, Detroit, MI, USA). Mice were killed 3 days post-
injection and peritoneal macrophages were harvested after killing
by rinsing the peritoneal cavity with two 5 mL washes of OM5
media supplemented with 5.0 U/mL heparin (Sigma, St. Louis,
MO, USA). Exudate cells were plated and allowed to adhere. Non-
adherent cells were removed by rinsing the cultures. Greater than
90% of the remaining adherent cells were macrophages (CD11b+
cells). Bone marrow-derived dendritic cells were prepared by
standard methods and puriﬁed by ﬂow cytometry as described in
Carson et al. (1999). Lymphocytes were isolated from lymph nodes
of naı ¨ve mice by ﬂow cytometry as previously described in Carson
et al. 1999.
Microglia and macrophage isolation from healthy and inﬂamed
adult CNS
Microglia were isolated as previously described (Carson et al. 1999)
from the CNS of healthy adult (8–12 weeks old) C57Bl/6J mice or
from mice injected intracerebrally with LPS (100 ng/mL) and
interferon (IFNc, 10 U/mL) in a total volume of 5 lL. In brief, mice
were killed by halothane inhalation, and the brains of the mice
rapidly removed and mechanically dissociated. The cell suspension
was separated on a discontinuous 1.03/1.088 Percoll gradient and
microglia/macrophages were collected from the interface as well as
from the 1.03 Percoll fraction. Microglia and CNS-inﬁltrating
macrophages were puriﬁed by ﬂow cytometry using Allophy-
cocyanin-conjugated antibodies against pan-CD45 and phycoery-
thrin-conjugated antibodies against FcR/CD16/CD32 (Pharmingen).
Activated microglia were identiﬁed as FcR-positive, and CD45lo/
intermediate and macrophages identiﬁed as FcR-positive, CD45hi.
RNA extraction and reverse transcription
RNAwas extracted from isolated cells immediately after isolation as
previously described (Schmid et al. 2002). RNA concentration was
assessed by measuring the absorbance at 260 nm and was adjusted
to 1 lg/lL. RNA integrity and absence of genomic DNA were
veriﬁed by fractionating samples by electrophoresis in denaturing
gels. Gels were stained with ethidium bromide and the ratio of 28S
to 18S RNA was quantiﬁed. Two micrograms of RNA were RT
using ﬁrst strand cDNA synthesis kit according to manufacturer’s
instructions (Amersham Biosciences, Buckinghamshire, UK).
Quantitative real-time PCR analysis
The oligonucleotide primers used are listed in Table S1. Primers
were chosen to anneal with a DNA template at a temperature of
60 C and to encompass a coding fragment of 100–300 bp. qPCR
was performed as previously detailed in Melchior et al. (2002). In
brief, a constant amount of 200 ng cDNA from each RT or each
dilution of the appropriate standard, was ampliﬁed in 25 lLo f
TaqMan PCR Core Reagent (Applied Biosystems, Carlsbad, CA,
USA) according to the manufacturer’s instructions. The reaction
mixture consisted of 0.5 U of AmpliTaq Gold polymerase, each of
the four dNTPs (0.2 mM), with dUTP replacing dTTP, each pair of
primers (300 nM), and MgCl2 (3 mM ﬁnal concentration) in the
above-described Tris buffer. Ampliﬁcations were performed in an
ABI Prism 7700 Sequence Detector System (Applied Biosystems).
The reaction was started with a step of 10 min at 50 C for the
removal of uracyl residues incorporated into the cDNAs with 1 U of
uracyl-N-glycosylase (AmpErase reagent). This was followed by an
incubation of 10 min at 95 C for AmpliTaq Gold activation, then 40
cycles each consisting of 15 s at 95 C and 1 min at 60 C. At the end
of each experiment, ampliﬁcation products were fractionated by gel
electrophoresis to verify that they migrated as a single band with the
expected size. Each sample was analyzed in duplicate. For the
quantitative analysis, direct detection of PCR products was
performed by measuring the progressive increase in ﬂuorescence
emitted by the binding of SYBR Green to double-stranded DNA.
Data were normalized to the endogenous reference hypoxanthine
phosphoribosyl transferase (HPRT); then using the comparative
cycle threshold (CT) method, the amount of RNA transcripts were
expressed as a reference to a standardized unstimulated microglia
sample. CT was deﬁned as low as transcripts were abundant. For
validation of the ddCt method, we also used standards for calibration
of HPRT and Trem2 cDNA. Brieﬂy, PCR fragments that served as
standards for calibration of quantitative PCR were puriﬁed from
preparative gels with an extraction kit (QiAquick; Qiagen Ger-
many). Fragment concentrations were assessed by measuring their
absorbance at 260 nm and according to their respective molecular
weights; these standards were subsequently diluted to obtain 10
7,
10
6,1 0
5,1 0
4,1 0
3, and 10
2 copies per well. The copy number was
obtained by relating the ﬂuorescence measured at the CT in
unknown samples to the calibration curve derived from the
standards. Using the standard curve, it was veriﬁed that the absolute
copy number of HPRT transcripts was of the same order of
magnitude in all samples analyzed by qPCR.
In situ hybridization
In situ hybridization was performed on free-ﬂoating cryosections
sections as previously described (Schmid et al. 2002; Thrash et al.
2009, Papenfus et al. 2007). Brieﬂy, coronal sections were
hybridized at 55 C for 16 h with a
33P-labeled riboprobe
(10
7 cpm/mL). Myeloid cells and blood vessels were identiﬁed by
their ability to bind biotinylated tomato lectin (Vector Laboratories,
Burlingame, CA, USA). Bound biotinylated tomato lectin was
visualized by standard streptavidin, horseradish peroxidase-diami-
nobenzadine (DAB) methodology. Sections were mounted onto
Fisherbrand (Fisher Scientiﬁc, Pittsburgh, PA, USA) superfrost/plus
slides and dehydrated with ethanol and chloroform. Slides were
exposed for 3 days to Kodak X-AR ﬁlm and dipped in Ilford K-5
emulsion (Polysciences, Warrington, PA, USA). After 3 weeks,
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counter-stained with Mayer’s hematoxylin. Riboprobes were
prepared from antisense sequences corresponding to nucleotides
1282–1768 at the extreme 3¢-end of the untranslated region of the
large CXCL14 transcript to nucleotides 443–1005 within the open-
reading frame of the published CXCL14 sequence (accession #:
AF192557) and to the ﬁnal 600 nucleotides within the 3¢
untranslated region of C1qA (accession #: BC002086). Riboprobes
for Trem2 were generated from reported plasmids as previously
described (Schmid et al. 2002).
Northern blot
For Northern blots, 2 lg per lane of poly A+ or 10 lg per lane total
RNA were resolved by electrophoresis in a 1.5% agarose/1.2 M
formaldehyde gel, transferred to nylon membrane, and hybridized
with
32P-radiolabeled probes (Schmid et al. 2002 and Thrash et al.
2009).
TOGA and bioinformatic comparison of microglial and
macrophage transcriptomes
TOGA (Total Gene expression Analysis) analysis was performed as
previously described (Schmid et al. 2002) on mRNA samples
prepared from microglia and macrophages isolated from LPS/IFNc-
injected murine CNS. Brieﬂy, RNA samples were converted to
cDNA using a degenerate pool of biotinylated phasing primers that
initiated synthesis at the beginning of the poly(A) tail on each
mRNA. The cDNA collection was digested exhaustively with the
restriction endonuclease MspI and the 3¢ fragments were isolated by
strepavidin-bead capture. These were released from the beads by
cleavage with NotI, which recognized a site in the phasing primers.
The captured fragments were modiﬁed at their 5¢ ends to harbor a
start site for in vitro transcription by ligation of an oligonucleotide
adapter to the MspI overhang. Following incubation of the modiﬁed
fragments with T3 polymerase, a collection of RNA fragments was
produced corresponding to the 3¢ portion of each starting mRNA,
from its most 3¢ MspI recognition sequence to the beginning of its
poly(A) tail, with each fragment ﬂanked by linker tags of known
sequence. For the initial PCR step, ﬁrst-strand cDNA was prepared
from the RNA pool by RTand used in four separate PCRs, in which
a5 ¢ primer that extends by one of four possible nucleotides beyond
the MspI site (N1 position) was paired with a universal 3¢ primer to
generate an N1-speciﬁc double-stranded DNA template. In the ﬁnal
step, 256 primers corresponding to all possible permutations of the
four nucleotides immediately adjacent to the MspI recognition site
(N1N2N3N4) were matched with the appropriate N1 template and
utilized in individual robotically performed PCRs paired with a
ﬂuorescent primer to produce 256 non-overlapping pools of
products, and these products were separated by electrophoresis.
This process assigned each product a digital sequence tag address:
an eight-nucleotide sequence (the four MspI recognition and the
adjacent four parsing nucleotides) and a length, both of which were
attributes of the individual mRNAs. The amplitudes of the
ﬂuorescent PCR products corresponded to the initial concentrations
of their parent mRNAs. The amplitudes were automatically collated
into a database, indexed by their digital sequence tag addresses that
could be queried electronically to identify mRNAs, the concentra-
tion of which differed among the experimental samples.
Duplicate TOGA analysis of gene expression was performed on
each of the cell population samples described in Fig. 1c and
expression of 19023 different mRNAs was detected. Between each
of the samples, pair-wise comparisons were made of the relative
expression levels of 19000 mRNAs detected by TOGA. From
these comparisons, linear correlation coefﬁcients were calculated in
a pair-wise fashion for each of the samples. The difference index
(DI) between each sample was simply calculated as 1 minus the
correlation coefﬁcient. The pairs of samples with the highest
correlation coefﬁcients (i.e., pairs with the least difference between
samples) provided the ﬁrst branching points. The peak data for these
pairs were then averaged and the resulting data set was used to
calculate new correlation coefﬁcients with other combined data sets
to identify the next branch points. This process was continued until
all samples were connected in a complete tree as shown in Fig. 1c.
Results
Functional differences between CNS-resident microglia and
acutely inﬁltrating macrophages have been identiﬁed (re-
viewed in Carson et al. 2006a,b, 2007), but as yet markers
able to distinguish these cell types in histological samples
have not. We previously compared differences in gene
expression between primary neonatal mixed glial culture
microglia and peritoneal macrophages treated for 22 h with
LPS (100 ng/mL) and IFNc (10 U/mL) using the gene
expression proﬁling method, TOGA (Schmid et al. 2002;
Carson et al. 2004). Here, we used real-time qPCR and
biological replicate samples of neonatal microglia and
peritoneal macrophages to validate and quantify the degree
of microglial-enriched expression of the 15 TOGA-identiﬁed
molecules (Table 1, column 1). Enriched expression in
Table 1 Comparison of differential gene expression in microglia and
macrophages when stimulated in culture versus when stimulated
within the intact adult murine CNS by LPS/IFN
Gene
Relative expression
in vitro: neonatal cultured
microglia/peritoneal
macrophages
Relative expression
ex vivo: adult CNS
microglia/CNS-inﬁltrating
macrophage
LOC620695 250.00 0.72
GPR84 100.00 0.76
Sal3 100.00 0.56
C1qA 100.00 2.56
NAV3 33.33 0.63
USP2 20.00 0.68
Tem7R/Plxdc2 14.29 1.14
Hspa4l 7.69 0.45
CXCL14 6.67 5.56
Rrbp1 6.67 1.49
Trim47 5.00 0.79
SPARC 4.00 1.47
Tmem176b 2.78 1.10
Trem2 2.44 9.09
TDC1D16 2.04 0.56
Shaded rows indicate molecules showing enriched expression in LPS/
IFNc activated microglia in vitro and in vivo.
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and Tmem176b (also known as TORID, LR8) to 100-fold for
complement component C1qA, GPR84, and hypothetical
protein LOC620695. The functions of many of these
molecules are still unknown. However, consistent with
identiﬁed neuroprotective functions of microglia, Trem2
and the tolerance-associated transcript, Tmem176b, each
have demonstrated functions in decreasing adaptive immune
responses when transfected into peripheral immune cells
(Louvet et al. 2005; Takahasi et al. 2007).
To test whether activated neonatal microglia successfully
predicted microglial-enriched gene expression in the adult
CNS, we quantiﬁed relative expression of the 15 TOGA
identiﬁed molecules in CNS-resident microglia and CNS-
inﬁltrating macrophages isolated from LPS/IFNc-injected
adult murine CNS. Intracerebral LPS/IFNc injection caused a
rapid, robust and transient, and self-resolving CNS inﬂam-
mation. Speciﬁcally, peripheral macrophages (deﬁned as
CD45hi cells) comprised < 1% of the myeloid cells isolated
from the unmanipulated healthy adult murine CNS, while all
CNS-resident microglia (CD45lo cells) were nearly MHC
class II negative (data not shown, Carson et al. 1998). By
contrast, CD45hi macrophages comprised 40% of the cells
isolated and nearly all microglia expressed detectable levels
of MHC class II, 22 h post-intracerebral LPS/IFNc injection
(data not shown; Carson et al. 1998). To provide polarized
populations of ex vivo microglia and macrophages, only cells
from the non-overlapping (boxed) regions of the CD45lo and
CD45hi ﬂow cytometry dot plot were collected by ﬂuores-
cence activated cell sorting for subsequent RNA isolation
(Fig. 1a).
Despite the high degree of enriched expression in activated
neonatal microglia, only 3 of the 15 original TOGA-
identiﬁed molecules were enriched in activated adult micro-
glia when compared with acutely inﬁltrating macrophages
isolated from LPS/IFNc injected CNS: C1qA, Trem2, and
CXCL14 (Table 1, column 3). The discrepancy between the
in vitro and in vivo data sets was primarily because of
increased expression of these molecules by CNS-inﬁltrating
macrophages. For example, Tmem176b was nearly unde-
tectable in peritoneal macrophages (unstimulated or stimu-
lated), but was strongly induced in CD45hi macrophages
inﬁltrating LPS/IFNc-injected murine CNS (Fig. 1b). These
data suggest that in vitro studies overestimated the molecular
differences between microglia and macrophages because the
peritoneal macrophages were not exposed to the regulatory
effects of the CNS micro-environment. By contrast the
cultured neonatal microglia isolated from mixed glia cultures
were exposed to astrocytes and oligodendrocytes in vitro.
To determine the relative similarity of total gene expres-
sion between CNS-resident microglia and CNS-inﬁltrating
macrophages, we compared the numbers and levels of total
mRNA transcripts detected by TOGA and expressed in
common between LPS/IFNc stimulated microglia and
macrophages. We previously reported comparative analysis
of the 15000 distinct mRNAs detected in TOGA proﬁling
studies of neonatal microglia and peritoneal macrophages
(Carson et al. 2004). In these in vitro studies, LPS/IFNc-
stimulated neonatal microglia showed greater similarity in
total gene expression to unstimulated microglia (DI of 0.194)
than to either unstimulated or LPS/IFNc-stimulated perito-
neal macrophages (DI between microglia and macrophag-
es = 0.359) (Carson et al. 2004). By contrast, comparative
analysis of the 19000 mRNAs detected in the ex vivo
TOGA proﬁling studies unexpectedly revealed that microglia
isolated from LPS/IFNc-injected mice showed greater sim-
ilarity in total gene expression proﬁles to CNS-inﬁltrating
macrophages (DI: 0.130) from LPS/IFNc-injected mice than
to microglia isolated from unmanipulated healthy adult
murine CNS (Fig. 1c). As a control for this bioinformatic
analysis, we compared the gene expression similarities of
ex vivo lymph node B cells, CD4 T cells, CD8 T cells, and
bone marrow-derived cultured dendritic cells proﬁled in the
same TOGA experiment. The gene expression patterns of
these cells grouped as predicted from known biology and
previously published proﬁling experiments (Fig. 1c). Spe-
ciﬁcally, both types of T cells showed greater similarity to
each other than to B cells and all lymphocytes displayed
greater similarity with each other than with all ex vivo
myeloid cells (microglia and macrophages) (Fig. 1c).
C1qA and Trem2, two of the three molecules identiﬁed by
qPCR as being enriched in adult microglia isolated from
inﬂamed adult CNS (Table 1), are known to be expressed by
microglia (Schmid et al. 2002; Takahasi et al. 2007; Farber
et al. 2009; Thrashet al. 2009). Microglial expression of both
C1qA (Fig. 2a and b) and Trem2 (Fig. 2c and d) was readily
detected in both the healthy and inﬂamed adult CNS using in
situ hybridization analysis. However, the in vivo expression
patterns of the two molecules differed in microglia. In Fig. 2,
we present the data from the healthy adult CNS, which lacks
inﬂammatory macrophage inﬁltrates to clearly depict microg-
lial (and not macrophage) expression of these molecules.
While nearly all microglia expressed C1qA, the level of
expression varied by twofold even in the healthy CNS when
the number of emulsion grains per microglia was used as a
measure of relative expression (Fig. 2a and b). By contrast,
notallmicroglia expressed Trem2in theadultCNS.In Fig. 2c
and d, Trem2-positive- and Trem2-negative microglia are
found in close proximity within the same brain region. These
datademonstratethatwhileexpressionofthesemoleculeswas
enriched in adult microglia, neither C1qA nor Trem2 is likely
to be a useful universal marker distinguishing microglia from
macrophages in CNS tissue sections. These data also
demonstrate that microglias are not just heterogeneous
between brain regions or during inﬂammatory responses but
even within the same healthy brain region.
CXCL14 was the third molecule identiﬁed as microglial-
enriched from the qPCR screen and was also a demonstrated
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been previously detected in CNS RNA but the brain regions
and cells expressing CXCL14 had not been reported
(Hromas et al. 1999; Cao et al. 2000; Frederick et al.
2000; Vadasz et al. 2007; Meuter and Moser 2008). Here,
we examined the expression pattern of CXCL14 in unma-
nipulated healthy and LPS/IFNc-injected adult murine CNS
using two non-overlapping riboprobes that showed identical
labeling in tissue sections (Figs. 2, 3 and Fig S1). CXCL14
expression was not regulated in vivo by LPS/IFNc (Fig. 4e,
and in situ hybridization data not shown). Therefore,
CXCL14 expression is depicted only by the unmanipulated
healthy adult CNS in Figs. 2e and f and 3 and Fig. S1.
Surprisingly, the majority of CXCL14 expression was
detected on lectin-negative cells (upward pointing arrows
Fig. 2e and f). While most microglia were negative for
CXCL14 expression (downward pointing single arrows
Fig. 2e and f), low-level expression of CXCL14 was detected
in rare microglia within the hippocampus, (downward
pointing double arrow Fig. 2e and f) and in microglia
located in the septum (Fig. 3a and b) and lateral striatum
(Fig. S1 and data not shown). Within these last two regions,
all cells including microglia expressed high levels of
CXCL14 (Fig. 3a and b, Fig. S1). These data indicate that
while CXCL14 mRNA is enriched in RNA pooled from all
adult ex vivo microglia, CXCL14 expression is characteristic
of only a very small subset of microglia in vivo.
An overview of CXCL14 expression in the entire brain is
depictedanddescribedinFig. S1.Inbrief,thehighestlevelsof
CXCL14 expression were observed in the septum, the islands
of Calleja, the interpeduncular nucleus, the hippocampus, and
the Purkinje layer of the cerebellum (Fig. S1). Cells express-
inghighlevelsofCXCL14werefoundthroughoutthecerebral
cortex but were most abundant in the cingulate cortex. In the
striatum,CXCL14expressiondelineatedalateralregionofthe
striatum that has not been previously recognized as a deﬁned
striatal structure. Most CXCL14+ cells were identiﬁed as glial
ﬁbrillary acidic protein negative, 2¢3¢-cyclic nucleotide
phosphodiesterase P-negative, and NeuN positive (data not
shown). While nearly all CXCL14-positive cells displayed a
GABAnergic neuronal phenotype (GABA-positive, large
nucleus, and cell body: downward pointing arrows, Fig. 3b–
d), not all GABAnergic neurons were CXCL14 positive
(upward pointing arrows, Fig. 3b and c).
Finally, we examined CXCL14 expression in vitro and
in vivo by Northern blot analysis (Fig. 4). CXCL14 is
encoded by two mRNA transcripts with identical open
reading frames (Hromas et al. 1999; Cao et al. 2000;
(a) (b)
(c) (d)
(e) (f)
Fig. 2 Heterogeneity of microglial gene
expression in healthy murine CNS. All
panels depict tissue sections prepared from
a healthy unmanipulated adult mouse. In all
panels, nuclei are labeled in blue with
hematoxylin; microglia, macrophages, and
blood vessels are labeled with tomato lectin
and visualized in brown with DAB. C1qA
(panels a, b), Trem2 (panels c, d), and
CXCL14 (panels e, f) expression were
detected using
33P-labeled gene-speciﬁc
riboprobes. Expression is visualized by
induction of black grains in the ﬁlm emulsion
coating each tissue section. In panels a, c,
and e, the focal plane is on the level of
emulsion. In panels b, d, and f, the focal
plane is on level of immunohistochemistry.
Downward pointing double arrows indicate
examples of microglia positive for gene
expression of C1qA (panels a, b), Trem2
(panels c, d), and CXCL14 (panels e, f).
Angled downward single arrows indicate
examples of microglia negative for gene
expression. Upward angled single arrows
indicate CXCL14 expression by lectin-neg-
ative cells. Panels a–d depict regions within
the cortex, panels e and f depict regions
within the hippocampus. DAB, diamino-
benzadine.
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2008). In cultured microglia (Fig. 4a), peritoneal macro-
phages (Fig. 4a), thymus (Fig. 4d), and secondary lymphoid
structures (Fig. 4d; lymph node, spleen) the smaller CXCL14
transcript predominates (transcript 2, Fig. 4). By contrast, in
non-immune organs including the CNS, the larger transcript
predominates (transcript 1, Fig. 4a, c and e). Northern blot
analysis conﬁrmed enriched CXCL14 expression in cultured
neonatal microglia when compared with peritoneal macro-
phages or bone marrow-derived dendritic cells (Fig. 4a).
Because primary microglia from mixed glial cultures were
derived from neonatal CNS cortices, we examined whether
microglial expression of CXCL14 was more abundant in the
embryonic or early postnatal CNS. By Northern blot
analysis, the ratio of larger to smaller CXCL14 transcript
did not change during development (Fig. 4b). By in situ
hybridization analysis, the identical pattern of CXCL14
expression was observed at all ages examined from postnatal
day 1 to 3 months (data not shown and Figs. 2 and 3,
Fig. S1). These data indicated that detection of high levels of
CXCL14 expression in neonatal microglia from mixed glial
cultures was not a consequence of these cells reﬂecting an
earlier stage of CNS development. Rather the robust
expression of CXCL14 in cultured neonatal microglia was
probably an artifact of culture in the absence of signals
provided by an intact functional CNS.
Discussion
Several studies have identiﬁed functional differences in
CNS-resident microglia and acutely inﬁltrating inﬂammatory
macrophages (reviewed in Carson et al. 2007). However, as
yet a universal marker that could be used to distinguish these
functionally different cells in inﬂamed CNS tissue sections
has not been identiﬁed. Here, we tested and conﬁrmed by
qPCR that a panel of 15 molecules previously identiﬁed by
TOGA gene proﬁling were enriched in LPS/IFNc-stimulated
neonatal microglia when compared with similarly treated
peritoneal macrophages.
Despite enriched expression from 2-fold to 250-fold in
activated neonatal microglia in vitro, the majority of these
TOGA-identiﬁed were not preferentially expressed in CNS-
resident microglia when compared with CNS-inﬁltrating
macrophages isolated from LPS/IFNc-injected adult murine
CNS. In large part, the failure to conﬁrm preferential
expression of 12 molecules in LPS/IFNc-activated CNS-
resident microglia was because of much higher expression of
these molecules in CNS inﬁltrating macrophages (CD45hi
(a) (b)
(c) (d)
(e) (f)
Fig. 3 CXCL14 expression in healthy mur-
ine CNS in microglia and GABA+ neurons.
Panel a is a single autoradiogram from the
series depicted in Fig. S1. Left pointing
arrow in panel a identiﬁes region of septum
depicted in panel b. Right pointing arrow in
panel a depicts cortical area depicted in
panels c and d. In panels b–f, nuclei are
labeled in blue with hematoxylin. In panel b,
microglia and blood vessels are labeled
with tomato lectin and visualized brown with
DAB. In panels c–f, GABA immunoreactivity
is visualized in brown with DAB. CXCL14
expression was detected using
33P-labeled
gene-speciﬁc riboprobes. Expression is
visualized by induction of black grains in the
ﬁlm emulsion coating each tissue section. In
panels b, c, and e, the focal plane is on the
level of emulsion. In panels d and e, the
focal plane is on level of immunohisto-
chemistry. Downward-angled single arrows
indicate examples of CXCL14+, GABA+
neurons in the cortex (panels c, d) and in
the hippocampus (panels e, f). The upward
pointing arrow indicates an example of
CXCL14 negative, GABA+ neurons in
the cortex (panels e, f). DAB, diamino-
benzadine.
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CD45hi cells). Three molecules were conﬁrmed by qPCR as
enriched in adult microglia from LPS/IFNc-injected adult
CNS (C1qA, Trem2, CXCL14), but in situ hybridization
analysis demonstrated that expression of these three mole-
cules was heterogeneous in adult microglia in both the
unmanipulated and inﬂamed CNS. Developmental regulation
accounts for the observed heterogeneous pattern of microglia
gene expression only in part. Before postnatal day 7, all
microglia were Trem2-positive (Thrash et al. 2009). After
eye opening in the pup, only subsets of microglia expressed
varying levels of Trem2 (Schmid et al. 2002; Carson et al.
2006a,b; Thrash et al. 2009). By contrast, microglial
expression of CXCL14 did not vary from postnatal day 1
adulthood.
The signiﬁcance of CXL14 expression in the intact
functional CNS is unknown. Because CXCL14 is a macro-
phage chemoattractant, it is tempting to speculate that it may
contribute to organizing the close apposition of microglia to
GABA-positive, CXCL14-positive neurons. However, as
yet, microglia have not been formally demonstrated to
respond to CXCL14 nor has the receptor for CXCL14 been
identiﬁed. In addition, it is unknown why regions with high
levels of CXCL14 expression do not show increased
susceptibility to macrophage or B-cell inﬁltration. Is this an
evidence of active immuno-suppression by the CNS envi-
ronment or evidence of the failure to produce active
bioavailable CXCL14 protein?
In aggregate, these data contribute to the growing literature
demonstrating that microglia cultured in the absence of
signals provided by an intact functional CNS do not fully
mimic microglia located within the intact adult CNS
(reviewed in Carson et al. 2007). Here, we show that
cultured microglia expressed high levels of molecules such
as CXCL14 that were rarely expressed by these cells in vivo.
In addition, these data conﬁrmed that microglial gene
expression was not homogeneous throughout the CNS.
Indeed, microglial phenotype, both in vivo and in vitro
appeared to be determined by local environmental cues.
Furthermore, the continuing failure to identify a deﬁnitive
microglial-speciﬁc marker suggests that any molecule
expressed by all microglia subsets in all micro-environments
will also be expressed by nearly all inﬂammatory macro-
phages. Finally, induced expression of ‘microglial-speciﬁc’
molecules with immunosuppressive functions by CNS-inﬁl-
trating macrophages adds to the growing literature that the
CNS actively regulates microglia and macrophage pheno-
types via a wide array of neuronal and glial-expressed
molecules (including CD22, CD200, fractalkine, and
vasoactive intestinal protein) (Getts et al. 2008 and reviewed
in Carson et al. 2007). The existence of active regulation of
CNS inﬂammation by the CNS itself has consequences for
the aging and diseased CNS. Failures in CNS immuno-
regulation have the potential to contribute to the onset and
progression of chronic neuroinﬂammation characteristic of
many neurodegenerative disorders.
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